Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Security

HKPD · Cellyan Biotechnology Co., Ltd

HKPDNASDAQCommon stockCurrentCIK 2007702Updated Sep 24, 2026

Company: Cellyan Biotechnology Co., Ltd

Name history
Hong Kong Pharma Digital Technology Holdings Ltd · through Dec 17, 2025

HKPD price & chart

Provider market data

Loading TradingView…

NASDAQ:HKPD on TradingView ↗

TradingView · Data may be delayed

About the company

Cellyan Biotechnology is a Cayman Islands exempted company, and each of the HK Subsidiaries is a Hong Kong company. Currently, there are no restrictions or limitations under the laws of Hong Kong on (i) foreign exchange or the conversion of HK dollars into foreign currencies and the remittance of currencies out of Hong Kong, (ii) the transfer of cash or other assets between Cellyan Biotechnology and any of the HK Subsidiaries, across borders, or to U.S. investors, or (iii) the distribution of earnings from the HK Subsidiaries to Cellyan Biotechnology or U.S. investors. However, if certain PRC laws and regulations, including existing laws and regulations and those enacted or promulgated in the future, were to become applicable to our HK Subsidiaries, to the extent our cash or assets are in Hong Kong or with a Hong Kong entity, such funds or assets may not be available to fund operations or for other use outside of Hong Kong due to interventions in or the imposition of restrictions and limitations on the HK Subsidiaries’ ability to transfer funds or assets by the PRC government. We cannot assure you that the PRC government will not intervene or impose restrictions on the HK Subsidiar

F-1 · 2026-03-27 · 0001213900-26-035450

Company description from the cited filing.

In the news

SEC disclosures

Recent filings

  1. 6-K filing

    6-K · 2026-09-24 · 0001213900-26-102776

  2. 6-K filing

    6-K · 2026-09-23 · 0001213900-26-102385

  3. 6-K filing

    6-K · 2026-09-10 · 0001213900-26-098532

  4. S-8 filing

    S-8 · 2026-08-13 · 0001213900-26-089057

  5. 20-F filing

    20-F · 2026-08-07 · 0001213900-26-086725

Show 5 more recent filings
  1. NT 20-F filing

    NT 20-F · 2026-07-31 · 0001213900-26-084011

  2. 6-K filing

    6-K · 2026-07-16 · 0001213900-26-078733

  3. EFFECT filing

    EFFECT · 2026-06-24 · 9999999995-26-002111

  4. F-3 filing

    F-3 · 2026-06-12 · 0001213900-26-068308

  5. EFFECT filing

    EFFECT · 2026-04-08 · 9999999995-26-001120

Financials

FY 2025 · USD
Revenue20,313,818USD · FY 2025
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

Net income-27,056USD · FY 2025
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

AssetsUSD · FY 2025
Cash · FY 2025
Operating income-2,284,587USD · FY 2025
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

Diluted EPS-0USD per share · FY 2025
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

Some figures are unavailable for this reporting year.

Balance-sheet figures are unavailable pending verification.

cash flow · annual statements
Line itemFY 2025
Cash flows from operating activities:
Profit or LossUSD-27,056
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

Additional Financial Items
AdjustmentsForFinanceCostsUSD43,145
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesUSD294,831
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

InterestPaidClassifiedAsOperatingActivitiesUSD97,667
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD1,002,588
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

ProceedsFromBorrowingsClassifiedAsFinancingActivitiesUSD769,922
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

ProceedsFromIssuingSharesUSD4,000,000
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesUSD85,072
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

RepaymentsOfBorrowingsClassifiedAsFinancingActivitiesUSD237,826
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2025
Cost of Goods and Services Sold
Selling, General and Administrative ExpenseUSD2,215,859
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

Total RevenueUSD20,313,818
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

Additional Financial Items
ApplicableTaxRatenumber0.17
Source

6-K · 2026-03-18 · 0001213900-26-030790

2025-04-01 to 2025-09-30

AverageEffectiveTaxRatenumber1.75
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

BasicEarningsLossPerShareUSD per share-0
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

CurrentTaxExpenseIncomeUSD63,168
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

DepreciationAndAmortisationExpenseUSD66,091
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

DilutedEarningsLossPerShareUSD per share-0
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

FinanceCostsUSD97,667
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

FinanceIncomeUSD1,741
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

GrossProfitUSD2,415,159
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

IncomeTaxExpenseContinuingOperationsUSD63,168
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

InterestExpenseOnLeaseLiabilitiesUSD34,775
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

OtherIncomeUSD1,466
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

ProfitLossAttributableToOwnersOfParentUSD-27,056
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

ProfitLossBeforeTaxUSD36,112
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

ProfitLossFromOperatingActivitiesUSD-2,284,587
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

TaxRateEffectOfForeignTaxRatesnumber1.87
Source

20-F · 2025-08-14 · 0001213900-25-076725

2024-04-01 to 2025-03-31

Lines labelled “Derived” are calculated from reported figures.

Offerings

Registration 333-294685

F-1 · 2026-03-27 · 0001213900-26-035450

Terms from the governing filing for this registration; not a claim that the offering is open today.